Although a variety of anti-vascular endothelial growth factor (anti-VEGF) drugs have been used to control choroidal neovascularization (CNV) in wet AMD, there are still deficiencies in the diagnosis and treatment of AMD (Gross et al., 2018; Zhu et al., 2021). The gene discussed is VEGFA; the disease is age-related macular degeneration.